- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-mer
- Ligands
- 17 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.6: 7 residues within 4Å:- Chain A: T.108, N.234, T.236
- Chain E: R.457, N.460, K.462, E.465
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.14: 8 residues within 4Å:- Chain A: R.457, K.458, S.459, N.460, E.465
- Chain D: T.108, N.234, T.236
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:S.459, A:S.459
NAG-NAG-BMA.20: 8 residues within 4Å:- Chain D: R.457, K.458, S.459, K.462, E.465
- Chain E: T.108, N.234, T.236
No protein-ligand interaction detected (PLIP)- 34 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.21: 3 residues within 4Å:- Chain A: E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain A: F.59, N.61, P.631
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: N.148, N.149, M.153
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain A: N.280, N.282
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: N.343, S.371
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain A: N.616, E.619
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain A: N.603
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain A: N.331, Q.580
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain A: N.709
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain A: H.655, V.656, N.657
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain A: N.17
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain D: N.709, I.1130
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain D: E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain D: N.657
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain D: N.616
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain D: N.282
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain D: N.17, N.137
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain D: N.30, F.59, N.61
Ligand excluded by PLIPNAG.39: 5 residues within 4Å:- Chain D: H.146, N.149, K.150, S.151, E.154
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain D: N.331, Q.580
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain D: N.343, S.371
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain D: N.603
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain E: A.706, E.1072, N.1074
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain E: N.603
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain E: N.709
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain E: N.331, P.579, Q.580
Ligand excluded by PLIPNAG.47: 5 residues within 4Å:- Chain D: I.468, T.470
- Chain E: E.132, N.164, N.165
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain E: N.657
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain E: H.146, N.149, S.151
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain E: N.616, T.618
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain E: N.282
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain E: C.15, N.17
Ligand excluded by PLIPNAG.53: 5 residues within 4Å:- Chain E: N.30, F.59, S.60, N.61, P.631
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain E: N.343, S.371
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cerutti, G. et al., Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe (2021)
- Release Date
- 2021-03-24
- Peptides
- Spike glycoprotein: ADE
1-87 heavy chain: B
1-87 light chain: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
BE
CB
HC
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-mer
- Ligands
- 17 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 34 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cerutti, G. et al., Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe (2021)
- Release Date
- 2021-03-24
- Peptides
- Spike glycoprotein: ADE
1-87 heavy chain: B
1-87 light chain: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
BE
CB
HC
L